Fil LTD Eli Lilly & CO Transaction History

Fil LTD

$98.1 Billion
Q4 2024

A detailed history of Fil LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Fil LTD holds 173,780 shares of LLY stock, worth $151 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

173,780

Previous 268,891 35.37%

Holding current value

$151 Million

Previous $238 Million 43.68%

% of portfolio

0.14%

Previous 0.23%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$727.2 - $932.06 $69.2 Million - $88.6 Million	-95,111 Reduced 35.37%	173,780 $134 Million
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $9.14 Million - $11.4 Million	-11,833 Reduced 4.22%	268,891 $238 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $35.8 Million - $44.9 Million	49,403 Added 21.36%	280,724 $254 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $12 Million - $16.1 Million	20,327 Added 9.63%	231,321 $180 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $13.9 Million - $16.4 Million	-26,432 Reduced 11.13%	210,994 $123 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $1.4 Million - $1.94 Million	-3,230 Reduced 1.34%	237,426 $128 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $26.8 Million - $35.9 Million	76,481 Added 46.59%	240,656 $113 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $7.5 Million - $8.81 Million	-24,157 Reduced 12.83%	164,175 $56.4 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $144,054 - $167,852	448 Added 0.24%	188,332 $68.9 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $16.8 Million - $19.1 Million	56,614 Added 43.13%	187,884 $60.8 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $3.37 Million - $3.96 Million	-12,092 Reduced 8.43%	131,270 $42.6 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $24.1 Million - $30 Million	-102,835 Reduced 41.77%	143,362 $41.1 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $1.43 Million - $1.77 Million	6,351 Added 2.65%	246,197 $68 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $2.08 Million - $2.56 Million	9,372 Added 4.07%	239,846 $55.4 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $5.1 Million - $6.6 Million	-28,265 Reduced 10.92%	230,474 $52.9 Million
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $33.7 Million - $44.6 Million	258,544 Added 132586.67%	258,739 $43.7 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $682 - $820	-5 Reduced 2.5%	195 $32,000
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $10,595 - $13,114	-89 Reduced 30.8%	200 $28,000
Q4 2019 Feb 07, 2020	SELL	$106.92 - $132.43 $21.3 Million - $26.4 Million	-199,469 Reduced 99.86%	289 $38,000
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $9.23 Million - $10 Million	-86,386 Reduced 30.19%	199,758 $22.3 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $2.2 Million - $2.57 Million	-19,878 Reduced 6.5%	286,144 $31.7 Million
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $12.6 Million - $14.9 Million	113,584 Added 59.02%	306,022 $39.7 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $8.2 Million - $9.19 Million	-77,453 Reduced 28.7%	192,438 $22.3 Million
Q3 2018 Nov 09, 2018	BUY	$85.86 - $107.31 $3.22 Million - $4.03 Million	37,522 Added 16.15%	269,891 $29 Million
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $13.5 Million - $15.4 Million	-177,699 Reduced 43.33%	232,369 $19.8 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $8.42 Million - $9.93 Million	-113,399 Reduced 21.66%	410,068 $31.7 Million
Q4 2017 Feb 12, 2018	SELL	$81.94 - $87.89 $11.3 Million - $12.1 Million	-137,502 Reduced 20.8%	523,467 $44.2 Million
Q3 2017 Nov 13, 2017	SELL	$77.07 - $85.54 $2.4 Million - $2.66 Million	-31,081 Reduced 4.49%	660,969 $56.5 Million
Q2 2017 Aug 29, 2017	BUY	N/A	692,050	692,050 $57 Million

Others Institutions Holding LLY

# of Institutions

4,282

Shares Held

757M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $826B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account